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Mena, [c] Agatha Bastida, [a] and Eduardo García-Junceda* [a] Enzyme promiscuity is a concept that in the last years is earning prominence in different fields of enzymology like biocatalysis, enzyme engineering or enzyme evolution. [1] Catalytic promiscuity is defined as the ability of an enzyme to catalyze more than one chemical transformation. [1b,c] Naturally occurring catalytic promiscuity provide the starting point for a Darwinian evolution of enzymes to new functions since this process must occur gradually, while maintaining organism fitness throughout.
[2] Tawfik and co-workers [3] have provided experimental evidence for the plasticity and "evolvability" [4] of promiscuous functions. These authors propose a model by which a protein acquires a new function, without losing the original one, and gene duplication may follow the emergence of a new function, rather than initiate it. Besides the intriguing implications that this theory of divergent molecular evolution has for protein evolution, its application to promiscuous enzymes allows to design enzymes with new catalytic activities. [5] A special case of catalytic promiscuity is the shown by metalloenzymes, where the variety of metallic ions that can be incorporated in the active site increase the range of chemical transformations that can be catalyzed by the enzyme. Thus, there are several examples showing that protein modification via the covalent attachment of ligands that incorporate metal ions or by incorporation of the catalytic metal ion alone in a suitable site for coordination, is a strategy that allows to obtain enzymes with either modified or completely new catalytic activities. [6] In this communication we describe the promiscuous behaviour of the dihydroxyacetone (DHA) kinase from Citrobacter freundii strain CECT 4626. This ATP-dependent DHAK is able to catalyse, beside the transfer of the γ-phosphate of the ATP to DHA, the cyclization of the FAD to yield riboflavin 4',5'-cyclic phosphate (4',5'-cFMN) (Scheme 1). This catalytic promiscuity is modulated by the divalent cation that forms the complex with the phosphorylated substrate. Although DHAK's are widely distributed in the three biological kingdoms, only their role in the catabolism of glycerol and in methanol assimilation in microorganisms have been well characterized. [7] In the bacteria C. freundii strain DSM 30040 [8] the entire dha regulon has been cloned and characterized at molecular level. [9] The kinetic properties and mechanism of the corresponding DHAK have been described [10] and the X-ray structure of the full-length DHAK in complex with its substrates has been elucidated. [11] This kinase is the only one known with an all-α nucleotide-binding domain. [12] From a biocatalytic point of view, ATP-dependent DHAK's have been given considerable attention because their feasibility for the simple and efficient obtaining of DHAP. [13] We have reported a multi-enzyme system for one-pot C-C bond formation catalysed by DHAP-dependent aldolases, based in the use of the recombinant DHAK from C. freundii CECT 4626, for in situ DHAP formation. [14] This enzyme (GeneBank Accession Nº DQ473522)
is a new isoform that differs in 22 aa from the enzyme of the DSM 30040 strain (see the Supporting Information).
During the progress of our own work towards the biochemical characterization of this enzyme, Cameselle and co-workers reported the molecular identity of recombinant human and rat liver purified FAD-AMP lyase (FMN cyclase) as ATP-dependent DHAK's. [15] These authors had previously published a series of papers in which they identified and characterized this Mn 2+ -dependent cyclase activity as the only enzymatic source of riboflavin 4',5'-phosphate (cFMN). [16] Human FMN cyclase displays 39.4% sequence identity with the DHAK from C. freundii CECT 4626. Thus, we decided to study if the DHAK displayed as well FMN cyclase activity (Scheme 2).
The time course of the reaction catalysed by DHAK in presence of FAD and Mn 2+ was followed by HPLC (see the Supporting Information). Chromatograms recorded at different reaction times shown that the decrease of the FAD peak was concomitant with the apparition of a new peak which retention time was coincident with the previously described for the cFMN. [16] Scheme 2. Promiscous reaction catalysed by DHAK from C. freundii CECT 4626 in presence of Mn 2+ .
This peak was purified and its identity unequivocally assigned by NMR and ESI-MS (see the Supporting Information). Thus, we were in presence of an enzyme able to catalyse two different reactions which were modulated by the divalent ion used as cofactor.
The different kinetic parameters for both reactions and for the different substrates are summarized in Table 1 . The catalytic efficiency (k cat /K M ) of DHAK for the different phosphorylated substrates was of the same order of magnitude (Table 1) . However, the kinase and cyclase specific activities are drastically affected by the Me 2+ used as cofactor ( Figure 1 ).
Meanwhile the kinase activity is almost independent of the Me 2+ , the cyclase activity increase almost 50 times when the cofactor used was Mn 2+ . Figure 2) .
A detailed analysis of the behaviour of the two activities as function of the Mn 2+ concentration showed that at low concentrations, the DHAK is able to catalyse both, the phosphorylation of DHA and the cyclization of the FAD (Figure 2) . However, from a concentration of Mn 2+ about 1.5 mM, the kinase activity begins to be inhibited while the cyclase activity reaches the saturation without detecting inhibition by effect of Mn 2+ .
Although, 1.5 mM is a concentration of manganese much more higher than the intracellular concentration of 10 μM usually assumed in the literature, [17] the Mn 2+ uptake systems of Enterobacteria can increase the cytoplasmic concentration of Mn 2+ over at least two orders of magnitude up to 1-3 mM on a time scale as short as a minute. [17, 18] Therefore, the cytoplasmic concentration of Mn 2+ could act as a real switch that turn the kinase activity off when the cyclase activity raises the maximum. It seems to be logical to assume that the promiscuous activities may occur in the ATP binding site of DHAK, owing to the structural similarities between ATP and FAD. To corroborate this hypothesis, we performed a series of inhibition and docking studies (see the Supporting Information).
The results summarized in Table 2 , shown that FAD and ATP are competing by the same binding site since ATP is a strong competitive inhibitor of the cyclase activity, meanwhile DHA is a poor uncompetitive inhibitor. Furthermore, AMP, which moiety is shared by both ATP and FAD, it is a competitive inhibitor of both activities. On the other hand, the behaviour of the FAD as inhibitor was more complex since it showed a mixed inhibition pattern which competitive component was higher than the uncompetitive one ( Figure 3 ).
[MnATP] (mM) This behaviour could be explained if FAD is bound to the active centre in two sub-sites, one of them coincident with the ATP binding site and the other probably related with the bound of the isoalloxazine ring of the FAD. This interpretation was supported by docking studies. Scheme 3 shown the minimized FAD bound in the ATP binding site of the DHAK from C. freundii strain DSM 30040 (pdb 1un9). 11 The phosphate groups of FAD are positioned where the ATP ones in the crystal structure which are coordinated by two Mg 2+ with the γ-carboxyl groups of aspartyl residues (Asp380, Asp385 and Asp387). Asp385 is at hydrogen bond distance (3.0 Å) of the -OH 5 involved in the cyclization of FAD. 16b Besides these residues, Val434 and Gly113, that do not participate in the binding of ATP, could be interacting with the isoalloxazine ring of the FAD.
Scheme 3. FAD docked into the ATP binding site of DHAK enzyme (stick) from C. freundii strain DSM 30040 (pdb 1un9). 11 In green are represented the aa that interact with both ATP and FAD; in black those that only interact with ATP and in red those residues that interact only with the FAD.
Interestingly, the kinetic parameters of the FMN cyclase activity determined for the DHAK from C. freundii CECT 4626 are quite different from those reported by Cameselle and co-workers for the rat liver enzyme. 16b The results summarized in Table 3 clearly shown that the rat liver enzyme is much more efficient as cyclase that the bacterial enzyme. Thus, the k cat /K M value of the rat enzyme is more than one order of magnitude higher than the value of the C. freundii enzyme. These results suggested that, in this case promiscuity is playing a role in the divergence of a novel enzyme function. Based on aminoacid sequence, the DHAK's from Citrobacter, plants and mammals grouped into the same class ( Figure 4 and reference 7).
Althought, the relationships between classes as shown by the branching order at the centre of this unrooted tree is unreliable, evolutionary information can be derived within each class. Therefore, our results suggest that enzymes in this separate branch has been under a process of divergent molecular evolution, along which the promiscuous function acquired higher activity and specificity. In conclusion, we have described the natural promiscuous behaviour of the DHAK from Citrobacter freundii CECT 4626. This catalytic promiscuity is modulated by the divalent cation that forms the complex with the phosphorylated substrate. Through kinetic and docking studies we have demonstrated that both activities are linked to the same binding site. The present results shown that the DHAK plasticity is involved in the adquisition of a new catalytic function according to the model proposed by Tawfik and others. -IDA) agarose was supplied by Agarose Bead Technologies (Spain). All other chemicals were purchased from commercial sources as reagent grade.
Cloning, overexpression and purification of DHAK from C. freundii CECT 4626
DNA manipulation was according to standard procedures (Sambrook et al. 1989). DNA template for amplification of the dhak gene was obtained from the Citrobacter freundii strain CECT 4626. Primers for PCR amplification were designed based on the nucleotide sequence of the dhak gene from the strain DSM 30040 (GeneBank Accession Nº U09771). The oligonucleotides 5´-ATATTAAGCTTCAAAACATTACTCAG-3´ and 5´-TATTACTCGAGTTACAGCCAGCGCACTGGC-3´ were used as leftward and rightward primers respectively (the recognition sequence for HindIII and XhoI are underlined). PCR amplification was performed in a 100 μl reaction mixture and subjected to 30 cycles of amplification. The cycle conditions were set as follows: denaturation at 94ºC for 1 min, annealing at 55 ºC for 1 min and elongation at 72 ºC for 1.5 min. The purified PCR product was digested with XhoI and HindIII and ligated into the doubled digested vector pRSET-A to yield the plasmid pRSET-dhak. This plasmid was transformed into E. coli BL21(DE3) competent cells. A colony containing the plasmid pRSET-dhak was cultured in Luria-Bertani (LB) broth containing ampicillin (250 μg/ml) at 37 ºC with shaking. When the culture reached an O.D 600nm of 0.5-0.6, DHAK expression was induced with IPTG (1 mM) and the temperature was dropped to 30 ºC. The culture was maintained O/N. After that, the culture was centrifuged at 10,000 x g during 10 min at 4 ºC and the resulting pellet was treated with lysozyme and DNase for protein extraction. 1 The recombinant protein containing an N-terminal 6xHis tag was purified in a Ni +2 -IDA-agarose column pre-equilibrated with sodium phosphate buffer (20 mM, pH 7.5). DHAK was eluted with the same buffer containing imidazole 0.25 M. All the fractions containing protein were pooled together and further purified by size-exclusion chromatography on a HiLoad 26/60 Superdex 75 PG column controlled using the AKTA-FPLC system (GE Healthcare Life Science). The column was developed in 50 mM phosphate buffer pH 7.2 containing NaCl (0.15 M) at a constant flow rate of 1.0 ml/min (SFigure 1). 
Protein analysis
Amino acid analysis of purified DHAK aliquots was performed at the Department of Biochemistry and Molecular Biology of the Complutense University of Madrid to determine the protein concentration. The absorption spectrum of different quantified samples allowed determination of the molar extinction coefficient of DHAK at 280 nm (ε 280 = 44432.5 M -1 ·cm -1 ). Peptide mass fingerprint analysis from the SDS-PAGE band corresponding to the putative recombinant DHAK was performed at the Proteomic Unit of the Spanish National Center of Biotechnology (Centro Nacional de Biotecnología, CSIC). Samples were digested with sequencing grade trypsin overnight at 37ºC. The analysis by MALDI-TOF mass spectrometry produces peptide mass fingerprints and the peptides observed can be collated and represented as a list of monoisotopic molecular weights. Data were collected in the m/z range of 800-3600. 29 peptides covering the major part of the amino acid sequence of the protein were identified (SFigure 2). Almost all the predicted tryptic peptides with molecular masses falling in the analyzed m/z range were found in the peptide mass fingerprint of the recombinant DHAK. Peptide mass fingerprinting verified that purified protein had the expected features of DHAK from C. freundii CECT 4626.
Enzyme activity assays
Phosphorylation of DHA was measured spectrophotometrically in a coupled enzymatic assay based in the reduction of DHAP to α-glycerophosphate, catalyzed by αGDH with concomitant oxidation of NADH to NAD FMN cyclase activity was determined by measuring the formation of 4',5'-cFMN from FAD by HPLC with A 430nm monitoring in reaction mixtures of 1 ml containing Tris-HCl (40 mM, pH 7.5), MnCl 2 (12 mM), FAD (0.25 mM) and DHAK. Full reaction mixtures were incubated from 10 to 60 min. HPLC was performed in an Inertsil ODS-2 column following the previously described assay with minor modifications. 2 The mobile phase employed was 20 mM sodium phosphate, pH 6.0, and methanol at a final concentration of 35% (v/v) and the chromatography was run under isocratic conditions at 1 ml/min flow rate (SFigure 3). One unit of cyclase activity was defined as the amount of enzyme that produces 1 μmol of 4',5'-cFMN per min under the above conditions. Steady-state kinetic assays for kinase activity were measured at 25 ºC in 96-well plates in a total volume of 0.3 ml. Measurements of kinetic parameters for DHA were performed with 0.08 μg/ml of purified DHAK at ten different DHA concentrations and with saturating concentration of [MgATP] 2-(5.0 mM) (SFigure 5A). Assays to determine the kinetic parameters for [MgATP] 2-complex were performed with 1.0 μg/ml of purified DHAK at sixteen concentrations of complex using a constants Mg 2+ excess of 40 mM and 2.5 mM of DHA (SFigure 5C). Assays to determine the kinetic parameters for [MnATP] were performed with 0.9 μg/ml of purified DHAK at twelve concentrations of complex using 2.5 mM of DHA (SFigure 5D). In order to avoid Mn 2+ excess inhibition (see Figure 2 ) the maximum MnCl 2 concentration used was 1.3 mM (7.5 fold lower than ATP concentrations in each kinetic point). Cyclase activity was measured at seven FAD concentrations in presence of MnCl 2 (12 mM) using 4.1 μg/ml of purified DHAK in 25 ºC kinetic (SFigure 5B) and 1.7 μg/ml of enzyme in 37 ºC kinetic. 
NMR procedures.
1 H and 13 C NMR spectra, using D 2 O as solvent, were recorded on a Varian SYSTEM 500 spectrometer equipped with a 5 mm HCN cold probe with field z-gradient, operating at 500. 13 1 H NMR and 2D gHSQC and gHMBC. Using the C11 resonance as the starting point, the assignments of all protons and carbons of the ribityl chain were obtained easily from gCOSY, gHSQC and gHMBC experiments (SFigure 9). The presence of a measurable 3 J( 31 P, 13 C) coupling constant for C3' indicated the existence of a cyclic phosphate fragment. NMR relevant data are collected in Table 1 showing a good concordance with those published for cFMN. 
Molecular docking studies
Docking simulation was conducted with AutoDock 3.0.4 4 which is a fully automated docking suited of programs, which employs a genetic algorithm (GA) as a search engine. The coordinates of the protein (1un9) 5 were taken from the Protein Data Bank. Before docking, compounds were minimised by Molecular mechanics (PM3) using MM3* force fields. Protein was prepared by eliminating heteroatoms and adding the hydrogen atoms (polar only). Polar hydrogen atoms and Gagsteir-Huckel were added to the compounds by using the auxiliary program AutoDock Tools (ADT). Energies were evaluated from recalculated potentials grids with molecular affinity potentials. Affinity grid files were generated using the auxiliary program Autogrid. The centers of the coordinates of the ligands were taken as the centers of the grids, and the dimensions of the grids were 76/63/123 for the FAD with points separated by 0.37 Å. After docking, the 50 solutions were clustered into groups with RMS deviations of 1 Å. The FAD conformers were bound to the ATPbinding domain of the enzyme (L-domain; Sfigure 10). The optimal docked conformer was to the global minimum giving docked energy of -5.38 Kcal/mol 
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SFigure 10. 3D structure of the dimeric DHAK from C. freundii DSM 30040. 4 In the N-terminal domain -K-domain (blue)-is where the DHA (purple) binding site is located. The ATP (dark blue) binding site is found in the C-terminal -L-domain (pink). In yellow are shown the amino acids in which differ the DSM 30040 isoform from the CECT 4626 isoform.
Sequence similarity searching and phylogenetic tree analysis
A similarity search for the DHAK from C. freundii CECT 4626 (GeneBank Accession Nº DQ473522) was performed by BLASTP 6 on the NCBI non-redundant SwissProt database using default settings. 30 proteins sequences with significant similarity were identified and analysed by BLAST pairwise alignment. The 17 proteins showing a maximum sequence differences below 0.75 were considered to build a matrix of distance according to the Kimura method. 7 Subsequently, the unrooted tree was derived by the Fast Minimum Evolution method, 8 as implemented at the NCBI server.
